Scheduling, administration, biomarkers, and practical guidance.
Safe default. Experimental: 3.2mg 2x/week or 1.6mg daily up to 16 weeks.
Safe default. Experimental: 5.0mg 2x/week or 300mcg-1.0mg daily. Max 3 months continuous, minimum 6-week break.
Safe default. Experimental: repeat more frequently under medical supervision. Site rotation recommended.
Safe default. Experimental: bi-annual 15-day courses.
Individualized after 4 weeks based on IGF-1 and insulin response. Requires physician oversight.
Mandatory cycling to prevent receptor desensitization and allow immune system recalibration.
Mimics natural nocturnal GH pulsatile release pattern and maximizes synergy with sleep-related repair.
Reduces GI side effects and provides overnight insulin sensitization to counteract rhGH-induced hyperinsulinemia.
Immune activation aligns with natural cortisol awakening response. Avoids potential sleep disruption from immune stimulation.
Tissue repair peaks during rest. Post-exercise timing leverages inflammatory signaling for enhanced healing response.
Consistent daily timing required for 10-day course. Morning administration aligns with immune circadian rhythm.